OBESITY, OVERWEIGHT, OR CHRONIC WEIGHT MANAGEMENT
Clinical trials for OBESITY, OVERWEIGHT, OR CHRONIC WEIGHT MANAGEMENT explained in plain language.
Never miss a new study
Get alerted when new OBESITY, OVERWEIGHT, OR CHRONIC WEIGHT MANAGEMENT trials appear
Sign up with your email to follow new studies for OBESITY, OVERWEIGHT, OR CHRONIC WEIGHT MANAGEMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New daily pill shows promise for weight loss in obesity trial
Disease control OngoingThis study tests a new daily pill, aleniglipron, to help people with obesity or overweight lose weight. About 220 adults will take either the drug or a placebo for 36 weeks. The goal is to see how much weight they lose and if the drug is safe.
Matched conditions: OBESITY, OVERWEIGHT, OR CHRONIC WEIGHT MANAGEMENT
Phase: PHASE2 • Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
New obesity drug shows promise in phase 2 fat-loss trial
Disease control OngoingThis study tests a new medication called aleniglipron (GSBR-1290) to see if it helps people with obesity lose body fat. About 71 adults with a BMI of 30 or higher will receive either the drug or a placebo for 40 weeks. The main goal is to measure changes in total body fat using a…
Matched conditions: OBESITY, OVERWEIGHT, OR CHRONIC WEIGHT MANAGEMENT
Phase: PHASE2 • Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics • Aim: Disease control
Last updated May 19, 2026 11:47 UTC